0001127602-15-029507.txt : 20151023 0001127602-15-029507.hdr.sgml : 20151023 20151023175627 ACCESSION NUMBER: 0001127602-15-029507 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151020 FILED AS OF DATE: 20151023 DATE AS OF CHANGE: 20151023 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0328 BUSINESS ADDRESS: STREET 1: 400 WOOD RD CITY: BRAINTREE STATE: MA ZIP: 02184 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fusco David CENTRAL INDEX KEY: 0001649182 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 151173604 MAIL ADDRESS: STREET 1: 400 WOOD RD CITY: BRIANTREE STATE: MA ZIP: 02184 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2015-10-20 0000313143 HAEMONETICS CORP HAE 0001649182 Fusco David 400 WOOD ROAD BRAINTREE MA 02184 1 EVP, Global Human Resources Common Stock 2015-10-20 4 A 0 2736 .01 A 5415 D Non-qualified Stock Option (Right to Buy) 31.97 2015-10-20 4 A 0 12030 31.97 A 2016-10-20 2022-10-20 Common Stock 12030 12030 D Performance Shares 0 2015-10-20 4 A 0 5473 0 A 2018-09-30 2018-12-31 Common Stock 5473 5473 D Restricted Stock Unit Grant which vest 25% per year over 4 years following the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan. Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant. Performance Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Performance Share Unit based on the performance of Haemonetics stock price relative to the Standard & Poors Health Care Equipment Index. The number of Performance Share Units (and therefore the number of shares payable) will depend on the Company's stock price performance between October 1, 2015 and September 30, 2018. The Performance Share Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to twice the target amount in column 5. The Performance Share Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d). /s/ Alexander P. Steffan, attorney-in-fact for Mr. Fusco 2015-10-23